NCT04793022

Brief Summary

This study is comparing total intravenous anesthesia with propofol with a regional nerve block against general anesthesia with a regional nerve block on the primary endpoint of time to meet discharge criteria.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Feb 2021

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2021

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 22, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2023

Completed
Last Updated

February 8, 2023

Status Verified

January 1, 2023

Enrollment Period

2.5 years

First QC Date

February 22, 2021

Last Update Submit

February 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to meet discharge criteria

    How long it takes until the patient is ready to be discharged from the PACU

    Immediately after the intervention/procedure/surgery

Secondary Outcomes (6)

  • Pain Scale

    Baseline, pre-intervention/procedure/surgery, and up to 21 days after procedure.

  • Number of procedures requiring anesthetic intervention during surgery

    During the intervention/procedure/surgery

  • Satisfaction scale

    Up to 21 days after procedure.

  • post-anaesthesia care unit (PACU) I to post-anaesthesia care unit (PACU) II transition time

    Immediately after the intervention/procedure/surgery

  • Antiemetic use in PACU

    Immediately after the intervention/procedure/surgery

  • +1 more secondary outcomes

Study Arms (2)

TIVA-Propofol

EXPERIMENTAL

Intravenous anesthesia with Propofol

Drug: TIVA with Propofol

Inhaled Anesthesia

ACTIVE COMPARATOR

General Inhaled Anesthesia

Drug: Inhaled Anesthesia

Interventions

Total intravenous anesthesia with propofol

Also known as: Propofol
TIVA-Propofol

General anesthesia given with inhaled anesthetics

Also known as: General Anesthesia
Inhaled Anesthesia

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • Candidate for a shoulder arthroscopic procedure in the beach chair position

You may not qualify if:

  • American Society of Anesthesiologists (ASA) level 4 or above
  • History of brachial plexus injury
  • Chronic Obstructive Pulmonary Disorder
  • Unstable Asthma
  • BMI greater than 40
  • Allergy to local anesthesic (bupivacaine)
  • Contralateral phrenic nerve impairment
  • History of Difficult Airway
  • Poorly Controlled Gastroesophageal Reflux Disease
  • Known Aspiration Risk
  • Surgery not performed at the Roanoke Ambulatory Surgical Center
  • Pregnant patients or patients who have a positive pre-operative human chorionic gonadotropin (beta-HCG) pregnancy test
  • Coagulopathies
  • Allergy to propofol
  • Patient request for specific anesthesia method

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carilion Clinic Institute of Orthopedics and Neurosurgery

Roanoke, Virginia, 240176, United States

Location

MeSH Terms

Conditions

Rotator Cuff InjuriesMusculoskeletal DiseasesAthletic Injuries

Interventions

PropofolAnesthesia, General

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsAnesthesiaAnesthesia and Analgesia

Study Officials

  • John Tuttle, MD, MS

    Carilion Clinic Ortho Surgeon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2021

First Posted

March 11, 2021

Study Start

February 2, 2021

Primary Completion

August 1, 2023

Study Completion

August 1, 2023

Last Updated

February 8, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Data will be collected, de-identified, and published in a manuscript once the study is completed.

Locations